Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for Prevention of Preeclampsia Recurrence
NCT00986765Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2009
- Primary completion
- Nov 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in preeclampsia, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2009; status: completed.
02
Drugs
enoxaparin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT00986765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986765.